AMZN
Amazon.com, Inc.
AMZN has the edge over MLKN overall, supported by stronger modeled upside and lower modeled downside.
MLKN
MillerKnoll, Inc.
MLKN offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
MLKN Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Under pressure |
MLKN's profitability and cash flow are currently healthy, and its revenue is stable, but its balance sheet is under pressure.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN has the edge over MLKN in the historical PE scenario, which offers more potential upside but is not a forecast.
MLKN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 11x | $21.33 | — |
| Cheap | 15x | $21.02 | -1.5% |
| Current | 15x | $21.33 | — |
| Fair | 26x | $37.13 | +74% |
| Expensive | 52x | $73.38 | +244% |
Historical ranges are pointers, not guarantees.
MLKN's PE is in its cheap range at 15x. If earnings grow as analysts expect, today's price would be 11x next year's earnings.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
MLKN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Stable | |
| Stable | |
| Limited | |
| Low |
Analysts expect MLKN's earnings to grow, with its revenue and profitability holding steady. However, they disagree widely on these estimates.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over MLKN on earnings, with more consistent year-over-year improvement.
MLKN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.93 | +37% |
| Q3 2026 | $1.41 | +$1.64 |
| Q2 2026 | $1.32 | +$1.86 |
| Q1 2026 | $0.16 | -62% |
| Q4 2025 | -$0.37 | -141% |
| Q3 2025 | -$0.23 | -126% |
| Q2 2025 | -$0.54 | -149% |
| Q1 2025 | $0.42 | -56% |
| Q4 2024 | $0.91 | +36% |
MLKN has returned to profit: it earned $1.41 per share over the past year, after losing money the year before.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over MLKN on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over MLKN on profitability, with a higher operating margin.
MLKN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $923.4M | -3.4% |
| Q2 2026 | $1B | +4.4% |
| Q1 2026 | $926.6M | +5.8% |
| Q4 2025 | $955.2M | -1.6% |
| Q3 2025 | $955.7M | +11% |
| Q2 2025 | $961.8M | +8.2% |
| Q1 2025 | $876.2M | +0.4% |
| Q4 2024 | $970.4M | +2.2% |
MLKN's revenue fell from its 2022 peak and has held roughly level since: $923M last quarter, down 3.4% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.6% | 0 points |
| Q2 2026 | 5.1% | -0.6 points |
| Q1 2026 | 4.8% | +14 points |
| Q4 2025 | 5.1% | -1.4 points |
| Q3 2025 | 5.6% | +3.8 points |
| Q2 2025 | 5.7% | +3 points |
| Q1 2025 | -9.4% | -14 points |
| Q4 2024 | 6.4% | +0.1 points |
MLKN's operating margin was 5.6% last quarter, about level with the same quarter a year ago.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
MLKN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $16.6M | +$37.9M |
| Q2 2026 | $25.9M | -18% |
| Q1 2026 | $39M | +0.5% |
| Q4 2025 | $34M | +3% |
| Q3 2025 | -$21.3M | -$19.8M |
| Q2 2025 | $31.4M | -44% |
| Q1 2025 | $38.8M | -12% |
| Q4 2024 | $33M | -47% |
MLKN has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has the edge over MLKN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
MLKN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1% | +719K shares |
| 1 year | +1.2% | +846K shares |
| 3 years | -7.5% | -5.7M shares |
| 5 years | +5.6% | +3.7M shares |
| Available history | +18% | +10.6M shares |
MLKN has 70M diluted shares, up 1.2% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2025 | $100,000 |
| Q1 2025 | $17.9M |
| Q4 2024 | $23.2M |
| Q3 2024 | $43.7M |
| Q2 2024 | $37.2M |
| Q1 2024 | $41M |
| Q4 2023 | $28M |
| Q3 2023 | $32M |
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN has the edge over MLKN on leverage, with a lower net debt burden relative to earnings.
MLKN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.3x | Elevated |
| Q2 2026 | 3.2x | Elevated |
| Q1 2026 | 3.2x | Elevated |
| Q4 2025 | 5.4x | High |
| Q3 2025 | 5.1x | High |
| Q2 2025 | 5.9x | High |
| Q1 2025 | 7.0x | High |
| Q4 2024 | 4.0x | Elevated |
MLKN's net debt is about 3.3 years of its operating earnings (EBITDA), down from 5.1 years a year ago.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
MLKN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.3 | Neutral |
| Stochastic | 40.8 | Neutral |
MLKN's weekly RSI is 54 (neutral) and its Stochastic is 41 (neutral).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
MLKN PE vs Consumer Cyclical Sector
| Metric | MLKN | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 18x | 16% below |
| PE % | 18 | 47 | 29 pts below |
MLKN has the edge over AMZN on valuation relative to its sector.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has the edge over MLKN on trend strength, trading above more of its moving averages.
MLKN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $21.0 | 1.8% above |
| 20 week MA | $21.8 | 1.9% below |
| 50 week MA | $19.4 | 10% above |
| 100 week MA | $19.2 | 11% above |
| 200 week MA | $21.4 | 0.5% below |
MLKN's trend is mixed: it's above three of its five weekly moving averages, and 0.5% below its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has finished higher in five of the last six years, two of them by more than 50%. It's up 15% so far in 2026.
MLKN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $41.6 | $34.6 | -17% |
| 2021 | $34.6 | $37.6 | +8.6% |
| 2022 | $37.6 | $21.1 | -44% |
| 2023 | $21.1 | $26.7 | +26% |
| 2024 | $26.7 | $22.4 | -16% |
| 2025 | $22.4 | $18.1 | -19% |
| 2026 YTD | $18.1 | $21.3 | +18% |
MLKN has the edge over AMZN on returns for 2026, with the stronger performance.